Seventh Community Pharmacy Agreement

The signing of 7CPA demonstrates the government`s ongoing commitment to helping Australian patients through a community pharmacy. Since 1990, the remuneration received by pharmacists for the dispensing of drugs from the Pharmaceutical Benefits Scheme (PBS) and the regulation of the location of pharmacies have been governed by a number of agreements between the Australian government and the Pharmacy Guild of Australia (the Guild). Over time, these agreements have expanded their scope and now offer professional pharmacy programs and services. The 7th Community Pharmacy Agreement – signed last night in Canberra – provides safety and stability to 5,800 pharmacies in Australia and provides first-class pharmaceutical services to Australian patients. Since 2005, the Australian government has funded a community service bond (ESC) funding pool. The CSO Funding Pool ensures that all Australians have continuous access to all PBS drugs through community pharmacies. It provides financial support to pharmaceutical wholesalers and provides the entire supply of PBS drugs, regardless of where the pharmacy is being implemented and the relative delivery costs. 7CPA recognizes the crucial role community pharmacies play in improving the health of all Australians. The Community Pharmacy Agreement (CPA) is an agreement between the Pharmacy Guild of Australia and the Commonwealth Government that describes the amount of compensation for the dispensing of drugs covered by the Pharmaceutical Benefits Scheme (PBS). In addition to these and other initiatives, the agreement sets the price to pharmacists for the dispensing of drugs under the Pharmaceutical Benefits Scheme, which is expected to amount to $16 billion in Commonwealth spending over the five years of the agreement. Just as community pharmacies have experienced a period of considerable uncertainty and volatility as a result of the COVID 19 pandemic, so have pharmaceutical wholesalers. The Guild recognizes and supports the crucial role of the pharmaceutical distribution infrastructure, and the importance of its strength remains high.